Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether mirabegron and tadalafil improve glucose tolerance in adults with prediabetes and obesity. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cialis (tadalafil)
  • Myrbetriq (mirabegron)

Snippet

Sponsor: Philip Kern | Conditions: Pre-diabetes, Obesity | Phase 4 | Status: RECRUITING